Apexian Pharmaceuticals' Series A - III Round

Apexian Pharmaceuticals raised a round of funding on November 13, 2017. Investors include Elevate Ventures.

Apexian Therapeutics, formerly Apex Therapeutics, is a biotechnology company focused on developing novel compounds to treat cancer. The company's lead drug candidate – APX3330 – targets the APE1/R…

Articles about Apexian Pharmaceuticals' Series A - III Round: